226 related articles for article (PubMed ID: 15200043)
61. Recommendation for subclass evaluation of TNM stage iva papillary thyroid carcinomas: T4aN1b patients are at risk for recurrence and survival.
Wada N; Masudo K; Nakayama H; Suganuma N; Matsuzu K; Hirakawa S; Rino Y; Masuda M; Imada T
Ann Surg Oncol; 2008 May; 15(5):1511-7. PubMed ID: 18299932
[TBL] [Abstract][Full Text] [Related]
62. Consensus conference on well-differentiated thyroid cancer: a summary.
Pasieka JL; Rotstein LE
Can J Surg; 1993 Aug; 36(4):298-301. PubMed ID: 8370008
[TBL] [Abstract][Full Text] [Related]
63. Surgery of thyroid cancer: twelve years' personal experience.
Pareschi R; Mincione A; Destito D; Mola M; Righini S; Assi A; Dottorini M
Acta Otorhinolaryngol Ital; 2004 Dec; 24(6):348-53. PubMed ID: 15952685
[TBL] [Abstract][Full Text] [Related]
64. Risk factors for permanent laryngeal nerve paralysis in patients with thyroid carcinoma.
Sevim T
Clin Otolaryngol; 2007 Oct; 32(5):378-83. PubMed ID: 17883559
[TBL] [Abstract][Full Text] [Related]
65. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA
Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605
[TBL] [Abstract][Full Text] [Related]
66. [Differentiated thyroid cancer--staging and prognostic systems].
Dănilă R; Andriescu L; Grigorovici A; Dragomir C; Găluşcă B; Vulpoi C; Ungureanu C; Mogoş V
Rev Med Chir Soc Med Nat Iasi; 2005; 109(1):71-6. PubMed ID: 16607831
[TBL] [Abstract][Full Text] [Related]
67. Papillary thyroid cancer: pathological parameters as prognostic factors in different classes of age.
Miccoli P; Minuto MN; Ugolini C; Panicucci E; Massi M; Berti P; Basolo F
Otolaryngol Head Neck Surg; 2008 Feb; 138(2):200-3. PubMed ID: 18241716
[TBL] [Abstract][Full Text] [Related]
68. Prognostic factors in follicular carcinoma of the thyroid--a multivariate survival analysis.
Besic N; Auersperg M; Golouh R
Eur J Surg Oncol; 1999 Dec; 25(6):599-605. PubMed ID: 10556007
[TBL] [Abstract][Full Text] [Related]
69. Locally advanced thyroid cancer: therapeutic options.
Avenia N; Ragusa M; Monacelli M; Calzolari F; Daddi N; Di Carlo L; Semeraro A; Puma F
Chir Ital; 2004; 56(4):501-8. PubMed ID: 15452988
[TBL] [Abstract][Full Text] [Related]
70. [Surgical management of upper mediastinal lymph nodes metastases from thyroid carcinoma].
Li ZJ; Miao XX; Tang PZ; Xu ZG; Zhang DC
Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):145-7. PubMed ID: 16750024
[TBL] [Abstract][Full Text] [Related]
71. [Effect of primary surgical therapy on the course of C-cell carcinoma of the thyroid gland].
Colombo-Benkmann M; Raff J; Raue F; Klar E; Herfarth C
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1041-3. PubMed ID: 9931784
[TBL] [Abstract][Full Text] [Related]
72. Neck management in medullary thyroid carcinoma.
Oskam IM; Hoebers F; Balm AJ; van Coevorden F; Bais EM; Hart AM; van den Brekel MW
Eur J Surg Oncol; 2008 Jan; 34(1):71-6. PubMed ID: 17555910
[TBL] [Abstract][Full Text] [Related]
73. [Lymphectomy for well differentiated or "aggressive" thyroid malignancies. Indications, complications and results of our experience].
Marchesi M; Biffoni M; Trinchi S; Turriziani V; Fiengo L; Campana FP
Chir Ital; 2005; 57(2):145-51. PubMed ID: 15916139
[TBL] [Abstract][Full Text] [Related]
74. Clinical outcomes in older or younger patients with papillary thyroid carcinoma: impact of lymphadenopathy and patient age.
Wada N; Masudo K; Nakayama H; Suganuma N; Matsuzu K; Hirakawa S; Rino Y; Masuda M; Imada T
Eur J Surg Oncol; 2008 Feb; 34(2):202-7. PubMed ID: 18023321
[TBL] [Abstract][Full Text] [Related]
75. Safety of modified radical neck dissection for differentiated thyroid carcinoma.
Kupferman ME; Patterson DM; Mandel SJ; LiVolsi V; Weber RS
Laryngoscope; 2004 Mar; 114(3):403-6. PubMed ID: 15091209
[TBL] [Abstract][Full Text] [Related]
76. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer.
Handkiewicz-Junak D; Wloch J; Roskosz J; Krajewska J; Kropinska A; Pomorski L; Kukulska A; Prokurat A; Wygoda Z; Jarzab B
J Nucl Med; 2007 Jun; 48(6):879-88. PubMed ID: 17536106
[TBL] [Abstract][Full Text] [Related]
77. Outcome predictors and impact of central node dissection and radiometabolic treatments in papillary thyroid cancers < or =2 cm.
Perrino M; Vannucchi G; Vicentini L; Cantoni G; Dazzi D; Colombo C; Rodari M; Chiti A; Beck-Peccoz P; Fugazzola L
Endocr Relat Cancer; 2009 Mar; 16(1):201-10. PubMed ID: 19106146
[TBL] [Abstract][Full Text] [Related]
78. Papillary thyroid carcinoma with distant metastases: survival predictors and the importance of local control.
Sugitani I; Fujimoto Y; Yamamoto N
Surgery; 2008 Jan; 143(1):35-42. PubMed ID: 18154931
[TBL] [Abstract][Full Text] [Related]
79. An evaluation of lymph node yield and lymph node ratio in well-differentiated thyroid carcinoma.
Beal SH; Chen SL; Schneider PD; Martinez SR
Am Surg; 2010 Jan; 76(1):28-32. PubMed ID: 20135936
[TBL] [Abstract][Full Text] [Related]
80. Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma.
Rivera M; Ghossein RA; Schoder H; Gomez D; Larson SM; Tuttle RM
Cancer; 2008 Jul; 113(1):48-56. PubMed ID: 18484584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
